THERAPY OF VENTRICULAR ARRHYTHMIAS - AN U PDATE

Sudden cardiac death is one of the major challenges in cardiology. In the last years, antiarrhythmic therapy is in a state of considerable f lux. There is a tendency to a stronger indication for antiarrhythmic t herapy, to a decreasing importance of the fast sodium-channel blockers , to an increasing importance of the class III agents and to nonpharma cological approaches in high risk patients (ICD).